World News: 01:03 GMT Thursday 10th October 2019. [Hagens Berman Sobol Shapiro LLP via Globe Newswire via SPi World News]
SAN FRANCISCO, Oct. 09, 2019 (GLOBE NEWSWIRE) -- Hagens Berman notifies Qiagen N.V. () investors of the firm’s ongoing investigation of possible violations of federal securities laws.
The investigation centers on whether Qiagen misrepresented or concealed regional demand for its molecular and genetic testing applications.
In response, the price of Qiagen shares steeply fell on October 8, 2019.
“We’re focused on investors’ losses and whether Qiagen falsely portrayed demand for its products,” said Hagens Berman partner Reed Kathrein.
Globe Newswire: 01:03 GMT Thursday 10th October 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.